Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-36,219
Closed -$2.4M 180
2023
Q4
$2.4M Sell
36,219
-5,070
-12% -$317K 0.14% 74
2023
Q3
$2.6M Sell
41,289
-553
-1% -$34.4K 0.17% 72
2023
Q2
$2.63M Sell
41,842
-2,407
-5% -$134K 0.16% 73
2023
Q1
$2.56M Buy
44,249
+9,311
+27% +$628K 0.16% 74
2022
Q4
$2.53M Buy
34,938
+3,060
+10% +$219K 0.16% 71
2022
Q3
$1.94M Buy
31,878
+7,300
+30% +$466K 0.13% 73
2022
Q2
$1.54M Buy
24,578
+3,704
+18% +$245K 0.1% 77
2022
Q1
$1.47M Buy
20,874
+3,460
+20% +$234K 0.08% 80
2021
Q4
$1.09M Buy
+17,414
New +$1.09M 0.06% 87

Other funds holding MET

Arvest Trust's MET Position: Q1 2024 in Review

Arvest Trust sold out of MetLife (MET) in Q1 2024, closing a stake of 36,219 shares — an estimated $2.4M sold.

Arvest Trust first reported a position in MET in Q4 2021 and held it in 9 quarters. The position peaked at $2.63M in Q2 2023. 1,279 funds tracked by Wall St. Rank hold MET as of Q1 2024.

  • Arvest Trust reported no remaining MetLife position as of Q1 2024 after selling out during the quarter.
  • Arvest Trust sold 36,219 MetLife shares in Q1 2024, an estimated $2.4M.
  • Arvest Trust first reported a position in MetLife in Q4 2021 and held it in 9 quarters.
  • Arvest Trust's MetLife position peaked at $2.63M in Q2 2023.
  • 1,279 funds tracked by Wall St. Rank held MetLife as of Q1 2024.

Based on Arvest Trust's 13F filing for Q1 2024, filed 15 May 2024.